Indeed there is a case being considered in the US Supreme Court in which Amgen, is attempting to get the Court to legitimize a despicable practice reported today.
via BNET Placebo Effects by Jim Edwards:
Amgen Just Asked the Supreme Court to Legalize Kickbacks
Amgen (AMGN) is asking the U.S. Supreme Court to legalize kickbacks in the drug industry, calling the federal False Claims Act “draconian” because some courts say it doesn’t allow doctors to take a kickback before applying to Medicaid or Medicare for reimbursement.
If Amgen gets its way, drug companies will find it easier to reward doctors with cash or credit for using their drugs, and taxpayer-funded healthcare programs would have to reimburse them for it unless they did their own investigations to prove that kickbacks had been paid. read here.
Via Reuters David Morgan in Washington:Analysis: States lobby against Medicaid cuts in Congress
An excerpt:
"State officials complain Medicaid is a problem because federal mandates make it hard for governors and lawmakers to address costs by adjusting benefits and eligibility." read here
To Save on Health Care, First Crack Down on Fraud
Published: September 26, 2011 By KATHLEEN SHARP
"LAST week, the Obama administration announced a plan to cut $320 billion over 10 years from the projected growth of Medicare and Medicaid. The plan would raise premiums and deductibles, lower payments to hospitals and require elderly people who receive care at home to make co-payments.
But before charging consumers more and eliminating valuable services, we should be much more aggressive in recovering money stolen from these taxpayer-supported programs. According to some estimates, health care fraud is a $250 billion-a-year industry, and about $100 billion of that is stolen from Medicare, the health care program for the elderly, and Medicaid, the insurance program for the poor and disabled." read here
I knew I couldn't be the only one to think that addressing the fraud and corruption is at least part of the solution!
Many of the drugs are the very same drugs that Washington, and other states have been successfully sued pharmaceutical companies for illegal marketing of the drugs. In spite of the fact the newer "atypical" neuroleptics are no safer or more efficacious, the drugs are still "preferred" by Washington Stat's Medicaid program. Services and programs are being cut, but no effort address Medicaid fraud or the unethical mental health practices which fuel it. There is no effort to stem the costs of prescribing more costly drugs which cause chronic diseases and neurological impairments which contribute to rising Medicaid costs...this is fiscally irresponsible; unethical, and morally repugnant.
The Amgen case is disappointing, it appears that it would serve to legitimize corrupt business practices. Should Amgen be successful, it would not bode well for the already strained Medicaid and Medicare programs---or for America in general, but it will cause more harm...
No comments:
Post a Comment